SCHEMBL30656349

SCHEMBL30656349

CN(C)CCNC(=O)c1c(C(F)F)sc2ccc(OCc3ccccc3)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.52
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
EDNRA P25101 1/20 0.46
MAOB P27338 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
EGFR P00533 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
LTA4H P09960 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR1D P28221 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656086 0.87 ALOX5 (0.55) ALOX5KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL30656275 0.85 EDNRA (0.52) KDM4EALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL30656301 0.84 EDNRA (0.47) KDM4EALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL30655991 0.83 SLC6A5 (0.51) KDM4EALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL26661130 0.82 EDNRA (0.53) KDM4ESMN1; SMN2MAPTEDNRAMAOB
SCHEMBL31351336 0.82 EDNRA (0.53) KDM4ESMN1; SMN2MAPTEDNRAMAOB
SCHEMBL26661120 0.82 EDNRA (0.56) KDM4EALDH1A1MAPTEDNRAMAOB
SCHEMBL31350321 0.80 ALDH1A1 (0.44) ALOX5KDM4EALDH1A1SMN1; SMN2EDNRA
SCHEMBL30656114 0.80 NAAA (0.44) KDM4EALDH1A1SMN1; SMN2MAPTEDNRA
SCHEMBL30656210 0.79 EDNRA (0.42) ALDH1A1SMN1; SMN2EDNRAMAOBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed